Don't miss this exciting opportunity to keep up to date with all that is going on in the world of PEM research.
​
​
08:30 – 08:50 Registration & coffee on arrival
08:50 – 9:00 Welcome & general housekeeping
Infection Trials
9:00 – 9:05 - Introduction to session
9:05 – 9:30 - EASY
9:30 – 9:45 - CURLY
9:45 – 10:00 - FROG
10:00 – 10:20 - CRESCENT
10:20 – 10:40 - Coffee
Respiratory Trials
10:40 – 10:45 - Introduction to session
10:45 – 11:05 - BronchStart VE and Maternal Attitudes
11:05 – 11:25 – BACHb
11:25 – 11:40 – PRECISE
11:40 – 12:00 - HOPSA / EVITA
12:00 – 12:30 Key note presentation 1"Guidelines and Gaps: the Anarchist's Tale" - Professor Andrew Bush MD FRCP FRCPCH Imperial College and Royal Brompton Hospital, London UK.
Lunch 12:30 – 13:30
Trauma/Ortho Trials
13:30 -13:35 Introduction to session
13:35 – 13:50 COWS
13:50 – 14:05 E-SCOOTERS
14:05 – 14:30 PiCBONE / CRAAFT
​
14:30 to 15:00 – Coffee
PEM Research prioritisation done – What now?
15:00 -15:05 Introduction to session
15:05 -15:30 – Round up of other ongoing studies not ready to report & round up of studies in development
15:30 – 16:10 – PEM Research prioritisation done – What now? (an overview of the processes between research idea to funded study)
16:10 – 16:50 - Key note presentation 2"From Concept to Reality: Setting Up an Emergency Medicine Research Entity -Prof Matt Reed (Chair RCEM Research, EMERGE Director) , Rachel O'Brien (EMERGE Research Nurse Manager) & Caroline Blackstock (Lead EMERGE Paediatric Nurse)
Closing remarks
​
A limited number of discounted tickets are available to support attendees who are unable to secure study funding. Please email perukimail@gmail.com for further information. The Scotsman Hotel is offering delegates 15% off of hotel rooms during the conference.
EVITA Trial
The EVITA Trial is a multi-million pound trial to find the best treatment for severe asthma in children. Three medicines used to treat children who have severe asthma attacks will be compared in a national trial. Asthma is the most common long-term condition among children and young people. EVITA will shed light on which of the three treatments: aminophylline, magnesium sulfate or salbutamol, is most effective. This will help to inform clinical guidelines in the future.
The EVITA trial has been awarded over £2.3 million from the National Institute for Health and Care Research (NIHR). Southampton’s Professor Graham Roberts and Dr Katrina Cathie will lead the trial, together with Professor Damian Roland in Leicester.
More information can be found at: www.evita.org.uk
News
PERUKI Chair Tom Waterfield outlines how to apply for the Kath Berry Prize
KATH BERRY PRIZE
Current funding application window is now OPEN!! In order to meet our vision, PERUKI are now able to support a number of studies each year withsmall amounts of funding. We are very keen on established academics supporting trainees andconsultants who are developing research interests and careers. All applications will be judged bythe RSC and then reviewed by both the PERUKI and APEM executive committees. Further detailsavailable at HERE
Dr Umana presents a summary of the Febrile Infants Diagnostic assessment and Outcome (FIDO) Study.
James Lind AlliancePriority SettingPartnership
In September, PERUKI successfully refreshed the list of research priorities for PEM across the UK and Ireland, ensuring they reflected the most pressing issues faced by patients, carers, and healthcare professionals today .In 2015, PERUKI published its first list of PEM research priorities, informed solely by healthcare professionals. Over the last nine years, this list guided PERUKI’s research agenda with many ofthese priorities now addressed. Recognising the importance of patient and carer input, the recen trefresh actively involved these stakeholder groups alongside healthcare professionals. Using the James Lind Alliance (JLA) methodology, over 650 research questions were collected from stakeholders across the UK and Ireland. After thematic merging and literature reviews, the questions were narrowed down through two surveys and a final consensus workshop. For the first time, patients, carers, and healthcare professionals collaborated equally to rank the top10 research priorities shown below. This comprehensive process, which spanned ten months, was guided by independent JLAfacilitators and included contributions from a young person advisory group. PERUKI began work translating these priority areas into detailed PICO (Population, Intervention,Comparison, Outcome) research questions at thePERUKI conference in September to guide futurestudies. Stay tuned for further updates as we movetoward addressing these key areas to improveemergency care for children and young people.